Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / cortisone / lipitor / lisinopril attending: addendum: pt. not discharged as planned on due to sob and supratherapeutic inr. coumadin held. target inr is 2.0-2.5. continued to monitor inr with plan to resume when inr < 2.5 at rehab. her diuresis was increased and her shortness of breath resolved. on chest xray there is a left pleural effusion that is small and continues to resolve with diuresis. her permanent pacemaker was interrogated , in sr with 1 degree avb and intermittent atrial fibrillation. she was discharged to rehab on pod 13. major surgical or invasive procedure: s/p cabgx3(lima->lad, svg->, )/mv repair(26mm annuloplasty band)/maze permanent pacemaker placement elective cardioversion pertinent results: 07:10am blood wbc-10.9 rbc-3.00* hgb-8.1* hct-25.4* mcv-85 mch-26.9* mchc-31.8 rdw-21.2* plt ct-673* 07:35am blood pt-38.2* inr(pt)-4.1* 07:17pm blood pt-40.5* inr(pt)-4.4* 07:10am blood pt-41.2* inr(pt)-4.5* 05:30am blood pt-37.5* inr(pt)-4.0* 05:40am blood pt-41.0* inr(pt)-4.5* 07:10am blood glucose-86 urean-17 creat-1.4* na-138 k-4.2 cl-99 hco3-30 angap-13 7:21 am urine source: cvs. **final report ** urine culture (final ): escherichia coli. >100,000 organisms/ml.. presumptive identification. escherichia coli. 10,000-100,000 organisms/ml.. second morphology. sensitivities: mic expressed in mcg/ml _________________________________________________________ escherichia coli | escherichia coli | | ampicillin------------ <=2 s <=2 s ampicillin/sulbactam-- <=2 s <=2 s cefazolin------------- <=4 s <=4 s cefepime-------------- <=1 s <=1 s ceftazidime----------- <=1 s <=1 s ceftriaxone----------- <=1 s <=1 s cefuroxime------------ 4 s 4 s ciprofloxacin--------- =>4 r =>4 r gentamicin------------ <=1 s <=1 s meropenem-------------<=0.25 s <=0.25 s nitrofurantoin-------- <=16 s <=16 s piperacillin---------- <=4 s <=4 s piperacillin/tazo----- <=4 s <=4 s tobramycin------------ <=1 s <=1 s trimethoprim/sulfa---- <=1 s <=1 s discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 3. levothyroxine 25 mcg tablet sig: one (1) tablet po daily (daily). 4. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po every six (6) hours as needed for pain. 5. ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily). 6. hydroxyurea 500 mg capsule sig: one (1) capsule po daily (daily). 7. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 8. iron (ferrous sulfate) 325 mg (65 mg iron) tablet sig: one (1) tablet po once a day. 9. coumadin please check daily inr and hold coumadin until inr 2.5 or less, then restart at 0.5mg daily with goal inr 2.0-2.5 for atrial fibrillation s/p maze 10. amiodarone 100 mg tablet sig: one (1) tablet po once a day. 11. furosemide 40 mg tablet sig: one (1) tablet po twice a day: please give 40mg twice a day for 7 days then decrease to 40mg daily. 12. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). 13. trimethoprim-sulfamethoxazole 160-800 mg tablet sig: one (1) tablet po bid (2 times a day) for 6 days. discharge disposition: extended care facility: - discharge diagnosis: coronary artery disease s/p cabg mitral regurgitation s/p mv repair atrial fibrillation s/p maze post op complete heart block s/p ppm pmh hypothyroidism chronic systolic and diasystolic heart failure asthma polycythemia hypertension elevated cholesterol peripheral neuropathy cataracts discharge condition: good discharge instructions: please shower daily including washing incisions, no baths or swimming keep left elbow at shoulder level or below due to pacemaker monitor wounds for infection - redness, drainage, or increased pain report any fever greater than 101 report any weight gain of greater than 2 pounds in 24 hours or 5 pounds in a week no creams, lotions, powders, or ointments to incisions no driving for approximately one month no lifting more than 10 pounds for 10 weeks please call with any questions or concerns please remove staples from posterior calfs on (3 weeks from surgery, please call if questions ) please check inr daily until 2.5 then restart coumadin at 0.5mg daily for goal inr 2.0-2.5 for atrial fibrillation s/p maze followup instructions: dr in 4 weeks () please call for appointment dr after discharge from rehab () please call for appointment device clinic in 3 months for pacer interrogation - please call to schedule already scheduled appointments: provider: , md phone: date/time: 10:30 provider: , md phone: date/time: 3:30 md procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters (aorto)coronary bypass of two coronary arteries intraoperative cardiac pacemaker other electric countershock of heart initial insertion of dual-chamber device initial insertion of transvenous leads [electrodes] into atrium and ventricle non-invasive mechanical ventilation excision or destruction of other lesion or tissue of heart, open approach open heart valvuloplasty of mitral valve without replacement artificial pacemaker rate check diagnoses: other iatrogenic hypotension thrombocytopenia, unspecified abnormal coagulation profile anemia, unspecified coronary atherosclerosis of native coronary artery intermediate coronary syndrome pure hypercholesterolemia mitral valve disorders urinary tract infection, site not specified congestive heart failure, unspecified unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation asthma, unspecified type, unspecified aortic valve disorders chronic kidney disease, unspecified atrioventricular block, complete other left bundle branch block other postprocedural status headache anticoagulants causing adverse effects in therapeutic use dehydration unspecified hereditary and idiopathic peripheral neuropathy examination of participant in clinical trial unspecified cataract acute on chronic combined systolic and diastolic heart failure polycythemia vera 

Answer: The patient is high likely exposed to